Nicotinamide riboside (NR) supplement specialist Chromadex’s has posted strong regional and global FY2020 financials, but the firm has issued a warning of ‘concerning behaviour’ from some nicotinamide mononucleotide (NMN) brands, especially in China.
New Zealand direct-selling company About Health has added a multi-ingredient nicotinamide riboside (NR)-based product to its existing range of healthy ageing dietary supplements.
ChromaDex has received approval from the Australian Therapeutic Goods Administration (TGA) for use of its patented nicotinamide ribosome chloride (NR) in listed complementary medicines in the country.
